1. Pink Sheet

Curative Gene Therapy Coverage May Need Government-Funded Risk Pools

 
• By Cathy Kelly

Former US FDA commissioner Scott Gottlieb makes a case for regional or national risk pools to ensure pediatric patients get timely access to gene therapy like the upcoming treatments for sickle cell disease.

The little girl in the water park swimming underwater and smiling - Image
Disparity in access between Medicaid and private plans for high-cost therapies could be particularly problematic, Gottlieb says. • Source: Shutterstock

Implementation of government-supported risk pools across US payers on a regional or state basis should be considered as a solution to paying for specific types of gene therapy, former FDA Commissioner Scott Gottlieb suggested at a meeting sponsored by the Duke Margolis Center for Health Policy on 11 September.

Many policy discussions about paying for curative therapies have focused on annuity models and value-based contracts, he noted

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access

Raising Drug Prices In The EU Could Take Years, Even If Pharma Effort Succeeds

 
• By Cathy Kelly

Manufacturers are engaging the European Commission and individual countries to allocate more health care spending to innovative medicines and align prices more closely to those in the US.

Non-Submissions To England’s NICE Surge Across All Disease Areas

 
• By Leela Barham

Blood cancer therapies were most proportionately impacted by the failure of pharmaceutical companies to submit evidence on their cancer therapies to England’s health technology appraisal body, shows analysis by the Pink Sheet.

PBMs No Longer Profit From Rebates But Plans Benefit; Should Sponsors Push More For Reform?

 
• By Cathy Kelly

Employers and other health plan sponsors may need to push for better targeted reforms that lower cost sharing for patients.